G&E Herbal Biotechnology Co., Ltd.
Research G&E Herbal Biotechnology Co., Ltd. (4911.TWO) on Bullrun: market cap TWD 1.88B, P/E 22.3, dividend yield 4.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4911.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyTWD
- Market capTWD 1.88B
- P/E22.3
- Dividend yield4.7%
- Financial periodQ2 2026
- RevenueTWD 34.44M
- Net incomeTWD 7.88M
- Free cash flowTWD 4.34M
- Gross margin70.7%
Valuation Snapshot
latest market cap is TWD 1.88B; P/E is 22.3; dividend yield is 4.7%.
Peer valuation comparison
Latest P/E is 22.34x versus a Healthcare sector median of 21.8x (2.5% above).
Latest dividend yield is 4.66% versus a Healthcare sector median of 2.4% (94.2% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 1.88B | 22.3 | 4.3% | 1.17 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.17 TWD, yield 4.7%.
About G&E Herbal Biotechnology Co., Ltd.
G&E Herbal Biotechnology Co., Ltd. engages in manufacturing and wholesale of western and chinese medicine, cosmetics, intellectual property rights, biotechnology services, medical device, and other unclassified food products in Taiwan. It offers HepaGent capsules, a liver protective agent; botanical food supplements; botanical anti-aging cosmetics, such as facial cleansing essence, botanic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; as well as lubricants.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is G&E Herbal Biotechnology Co., Ltd.'s market cap?
G&E Herbal Biotechnology Co., Ltd.'s market capitalization is TWD 1.88B.
What is G&E Herbal Biotechnology Co., Ltd.'s P/E ratio?
G&E Herbal Biotechnology Co., Ltd.'s price-to-earnings (P/E) ratio is 22.3.
Does G&E Herbal Biotechnology Co., Ltd. pay a dividend?
G&E Herbal Biotechnology Co., Ltd. has a dividend yield of 4.7%.
What does G&E Herbal Biotechnology Co., Ltd. do?
G&E Herbal Biotechnology Co., Ltd. engages in manufacturing and wholesale of western and chinese medicine, cosmetics, intellectual property rights, biotechnology services, medical device, and other unclassified food products in Taiwan. It offers HepaGent capsules, a liver protective agent; botanical food supplements; botanical anti-aging cosmetics, such as facial cleansing essence, botanic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; as well as lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.